Literature DB >> 4138197

Solid phase radioimmunoassay for identification of Herpesvirus hominis types 1 and 2 from clinical materials.

B Forghani, N J Schmidt, E H Lennette.   

Abstract

A solid phase radioimmunoassay (RIA) was developed for typing Herpesvirus hominis (HVH) strains isolated from clinical materials, and it also proved to be applicable to the direct detection and typing of HVH antigen in human and animal brain tissue. The procedure utilized virus-infected human fetal diploid cells or brain tissue smears in the bottom of 1-dram glass vials, antigen was detected through the use of intermediate HVH antisera produced in rabbits or hamsters and cross-absorbed with the HVH heterotype, and (125)I-labeled anti-species (rabbit or hamster) globulins produced in goats were used for detection of immune complexes. The cross-absorbed HVH antisera could be used at high dilutions in the RIA test, and they reacted with marked type-specificity in the RIA system. Specificity of the test was also improved by determining and using optimal concentrations of intermediate sera and of (125)I-labeled anti-species globulins. Results of typing HVH isolates by the RIA procedure agreed in all instances with those obtained by direct fluorescent antibody staining with cross-absorbed conjugates. The RIA procedure was effective and more sensitive than direct fluorescent antibody for demonstrating and typing HVH antigen directly in smears of infected human brain tissue.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4138197      PMCID: PMC186793          DOI: 10.1128/am.28.4.661-667.1974

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  15 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Avian oncornavirus group-specific antigen: detection and quantification by radioimmunoassay.

Authors:  R B Fritz; L F Qualtiere
Journal:  J Virol       Date:  1973-05       Impact factor: 5.103

3.  Virus antigens on the surface of infected cells: binding and elution of ( 125 I)-labelled antivirus antibody.

Authors:  J Rosenthal; K Hayashi; A L Notkins
Journal:  J Gen Virol       Date:  1973-02       Impact factor: 3.891

4.  Rapid micro-radioimmunoassay for the measurement of antiviral antibody.

Authors:  J D Rosenthal; K Hayashi; A L Notkins
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  Radioimmunoassay procedure for rabies binding antibodies.

Authors:  T J Wiktor; H Koprowski; F Dixon
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

7.  Radioimmune precipitation of group A arboviruses.

Authors:  J M Dalrymple; A Y Teramoto; R D Cardiff; P K Russell
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

8.  Radioimmunoassay of mammalian type-C viral proteins: interspecies antigenic reactivities of the major internal polypeptide.

Authors:  W P Parks; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

9.  Iodine-125-labeled antibody to viral antigens: binding to the surface of virus-infected cells.

Authors:  K Hayashi; J Rosenthal; A L Notkins
Journal:  Science       Date:  1972-05-05       Impact factor: 47.728

10.  Detection and assay of avian tumor virus group-specific antigen and antibody by the paired radioiodine-labeled antibody technique.

Authors:  J Weber; D S Yohn
Journal:  J Virol       Date:  1972-02       Impact factor: 5.103

View more
  23 in total

1.  Possible pitfalls in the study of IgG receptors produced by herpesvirus-infected cells. Brief report.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Comparison of biotinylated DNA and RNA probes for rapid detection of varicella-zoster virus genome by in situ hybridization.

Authors:  B Forghani; G J Yu; J W Hurst
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

4.  Improvements of a radioimmunoassay for measurement of viral antibody in human sera.

Authors:  W R Patterson; K O Smith
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

5.  Solid-phase radioimmunoassay of rubella virus immunoglobulin G and immunoglobulin M antibodies.

Authors:  K O Kalimo; O H Meurman; P E Halonen; B R Ziola; M K Viljanen; K Granfors; P Toivanen
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

6.  Screening for mumps immunity with the microtiter solid-phase radioimmunoassay.

Authors:  R Hernandez; M Just; A Bürgin-Wolff
Journal:  Infection       Date:  1976       Impact factor: 3.553

7.  Solid-phase radioimmunossay for rapid detection and identification of western equine encephalomyelitis virus.

Authors:  N H Levitt; H V Miller; G A Eddy
Journal:  J Clin Microbiol       Date:  1976-10       Impact factor: 5.948

8.  Rubella virus and rheumatoid arthritis.

Authors:  H Hart; B P Marmion
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

9.  Enzyme immunofiltration technique for rapid diagnosis of herpes simplex virus eye infections in a rabbit model.

Authors:  P H Cleveland; D D Richman; D C Redfield; D R Disharoon; P S Binder; M N Oxman
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

10.  Type specificity and use of human sera for rapid typing of herpes simplex virus isolates by an indirect peroxidase-labeled antibody technique: a comparison with three other methods.

Authors:  G Gerna; J Ditmore; R W Chambers
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.